Canal-U

Mon compte

Résultats de recherche

Nombre de programmes trouvés : 305
Autres

le (14m23s)

Petits moments dans une famille de musiciens sérers (Toilette, danse et guérissage), Joal, décembre 2009

décembre 2009, Joal, Sénégal01 Toilette et façonnage d'un nouveau né sous le regard de ses "tantes"02 Danse, jeu et sexe pour rire03 Jouer pour apprendre à danser04 Soigner des yeux par extraction du malActeurs- Ndey Degen, le nouveau-né fille et sa maman Mariama- Aissatou, la laveuse, grand mère et ses deux plus jeunes enfants Fama et Mama- Souley Thiam, le grand-père, griot et guérisseur, et sa cliente souffrant des yeux- des voisinesAuteur -réalisateur - caméra : Alain EpelboinMontage : Alain Epelboin, Annie Marx, Jean-Louis Durand
Voir la vidéo
Autres

le (4m16s)

Extraction de « vers » au marché de Thiaroy, (Pikine, Sénégal 1987),

Au bord de la voie de chemin de fer au marché de Thyaroie, un thérapeute aveugle, assisté de son épouse soigne les maux de tête, de dents, d'oreille, d'yeux.Il fustige le visage de son client (Babacar Diouf) avec des rameaux de niim (Azadirachta indica) qu'il trempe dans uen bassine d'eau. Au terme de l'opération apparaissent dans l'eau des animalcules bizarres représentant le malqu'il a extrait.Il s'agit d'une para tique d'extraction matérielle et symbolique du mal, une technique d'illusionisme basée sur les particularités des graines d'Ocimum basilicum d'être entourées de poils hydrofuges qui trempés dans l'eau l'entourent d'une pellicule blanchatre translucide.De ...
Voir la vidéo
Conférences

le (13m2s)

BRIO's facts and figures, structuration projects : Axe Cancer, translational research centerUpdate the implementation of BRIO

Update the implementation of BRIO Brio organisation is now fully up and running, and more than 100 research projects are currently active into the 6 integrated research programmes. In addition, major progresses were achieved at the level of the 7 strategic axes defined to structure and support cancer research in Bordeaux. The bioinformatics axis saw the recruitment of 4 bioinformaticians (2 funded by BRIO) and the creation of a transversal bioinformatics axis at the University. For the in-vivo research axis, a project to develop a translational research center is currently being developed ...
Voir la vidéo
Conférences

le (18m29s)

Sociology contribution to understanding the (no)diffusion of a medical innovation

Interface technology/clinical/SHS/public health : case study interventional radiology We will present results of an undergoing study on the socioeconomic processes of recognition in oncology of a long-standing medical innovation, the so-called interventional radiology (IR). This project is conducted by a multidisciplinary team gathering health sociologist, sociologist of science, economist of innovation, health lawyer and interventional radiologist, supported by INCa. With scientometrics and patent landscaping, we get an understanding of the IR discoveries’ chronology and identify the relationships established between science, medicine and industry. Through field observations and semi-directed interviews, we analyzed the strategies of legitimation of IR, seeking ...
Voir la vidéo
Conférences

le (19m21s)

Cost-effectiveness analysis for decision making, illustrated theory

Interface technology/clinical/SHS/public health : case study interventional radiologyIn a health care system with limited resources, each euro invested in a health care intervention is no longer available for another intervention. This imposes the need for a prioritization of health care interventions according to their additional value for money for maximizing health at a given cost. Cost-effectiveness analyses may answer two main questions: 1) does an intervention present sufficient value for money to be funded within a health system? The decision is based on the absolute value of the incremental cost-effectiveness ratio; 2) is further research needed to inform the decision ...
Voir la vidéo
Conférences

le (9m11s)

Innovation reimbursement

Interface technology/clinical/SHS/public health : case study interventional radiology Novel diagnostic and therapeutic strategies is a continuum of 3 strongly associated phases : clinical research, medico-economic evaluation of a novel strategy and deployment of innovation, the last one being a field of competence of centers of expertise such as SIRIC BRIO.In the full cycle of innovation, the money time is the major challenge of a large deployment. The main problem is to find money. But, in 2015, 3 changes should improve the innovation continuum. Should it be a progress, an obstacle, or both ?...Cette présentation a été donnée dans ...
Voir la vidéo
Conférences

le (15m1s)

Standardizing G8 evaluation

Non-pharmaceutical innovations and public healthManagement of the frail elderly with cancer is a challenge. Beside a poor outcome as compared to younger subjects, physicians will face increased risk of treatment-induced toxicity but also unexpected adverse events because of the underlying comorbidities and potential major consequences of these toxicities on the outcome because of frailty. In depth evaluation of the patient through geriatric assessment has been demonstrated as predictive of these adverse events but is time-consuming so that only a minority of cancer treatment hospitals will be able to propose it. Screening is part of the solution and G8 one of ...
Voir la vidéo
Conférences

le (19m53s)

Curing leukemia ?

Non-pharmaceutical medical innovations and public healthThe use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid leukemia (CML) and long-term survival has become a reality. Despite this outstanding progress, detection of minimal residual disease precludes therapy termination in most TKI-receiving patients. CML has thus turned into a chronic illness, raising concerns about long-term safety, medication adherence and healthcare costs. Although treatment cessation may be feasible in few selected patients achieving deep molecular responses, a definitive cure remains elusive owing to the discovery that TKIs spare quiescent leukemic stem cells (LSC). Understanding mechanisms ...
Voir la vidéo
Conférences

le (13m9s)

Multisarc

Translational science : how to move from biology to clinical applications Soft-tissues sarcomas represent an heterogeneous group of tumors. Stadard of care is surgical resection followed by radiotherapy. Patients with metastatic relapse are treated with chemotherapy but the overall survival is only approximatly 18 months. Actual research try to define new therapeutic targets, adapted to the type of sarcoma. The personalized medicine project aims to propose to patients with advanced sarcoma a targeted therapy based on the genomic and immunilogical profile. The main difference with other projects resides in ...
Voir la vidéo
Conférences

le (18m24s)

A new preclinical model to test the response of breast cancer to genomically targeted therapy

Translational science : how to move from biology to clinical applicationsThe rapid progress in next generation DNA sequencing technology (NGS) means it is now possible, in principle, to obtain a complete list of the genetic abnormalities in a tumour. In practice, clinicians use NGS to obtain a much shorter list of "actionable" mutations that can be targeted with available drugs or used as prognostic markers. Unfortunately, the mere presence of an actionable mutation does not guarantee a response to the cognate drug, as shown by the SAFIR1 study (André et al 2014). To spare patients unnecessary exposure to experimental drugs, ...
Voir la vidéo

 
FMSH
 
Facebook Twitter
Mon Compte